# Lupin Limited - Inspection Records

Source: https://www.keypedia.com/companies/lupin-limited/d2616722-956d-4898-88a7-c22b7bd321a2

> Inspection records and compliance data for Lupin Limited in Pithampur, None. Access full analysis and detailed observations.

---

## Details

- Name: Lupin Limited
- FEI Number: 3009107538
- City: Pithampur
- State: None
- Country Name: India
- Address Line 1: Unit 3, Plot No. M-1, Sez, Phase Ii, Misc Zone, Apperal Park, Dist Dhar
- Zip Code: None
- Facility Type: Manufacturing
- Business Operations: FDF MANUFACTURE, PACK

## Related Documents

- [483 - Lupin Limited - 2025-07-17](https://www.keypedia.com/records/483/lupin-limited/6f335fb2-3d0d-4d12-baba-38bdf30583a1) — source: FDA, date: July 17, 2025
- [483 - Lupin Limited - 2025-07-17](https://www.keypedia.com/records/483/lupin-limited/f4979117-c0b8-4ccb-bdf3-d5cab68eacb0) — source: FDA, date: July 17, 2025
- [FDA Inspection 1275680 - Lupin Limited - 2025-07-17](https://www.keypedia.com/records/fda_inspections/lupin-limited/3eb0abd3-7b93-490d-8975-7c91722b0398) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 17, 2025
- [483 - Lupin Limited - 2018-10-18](https://www.keypedia.com/records/483/lupin-limited/b652c954-f2ff-4c65-8d9f-10f5f29884ed) — source: FDA, date: October 18, 2018
- [483 - Lupin Limited - 2018-10-18](https://www.keypedia.com/records/483/lupin-limited/93074ac1-299c-4b90-9076-b1aac2c894e1) — source: FDA, date: October 18, 2018
- [FDA Inspection 1069052 - Lupin Limited - 2018-10-18](https://www.keypedia.com/records/fda_inspections/lupin-limited/88a13165-efb5-4ac2-b83a-10820d3770a5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 18, 2018
- [483 - Lupin Limited - 2017-06-16](https://www.keypedia.com/records/483/lupin-limited/d4595e7b-72b0-4e7a-afda-5ba3e7b0084b) — source: FDA, date: June 16, 2017
- [FDA Inspection 924395 - Lupin Limited - 2015-03-27](https://www.keypedia.com/records/fda_inspections/lupin-limited/9bb66820-1804-40a9-b414-45c7d452ee88) — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2015

## Related Companies

- [Quagen Pharma, LLC](https://www.keypedia.com/companies/quagen-pharma-llc/cd9437ab-54e0-430e-a568-3835f717bdf1)
- [Delpharm Dijon](https://www.keypedia.com/companies/delpharm-dijon/8f766752-64b7-4166-b421-2fbe7803560d)
- [Custom Research Labs Inc](https://www.keypedia.com/companies/custom-research-labs-inc/9b06cc46-d665-4363-bc5e-ab6cf9dfce31)
- [Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services](https://www.keypedia.com/companies/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/a2a924d8-594c-4f2a-a998-5cbd4c06c983)
- [Shilpa Medicare Limited](https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655)
- [Cyclomedica Australia Pty Ltd](https://www.keypedia.com/companies/cyclomedica-australia-pty-ltd/1e5c064b-db2c-472e-b270-eaf65f3ae1c7)
- [Teyro Labs Private Limited](https://www.keypedia.com/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b)
- [RK Pharma Inc.](https://www.keypedia.com/companies/rk-pharma-inc/04d6c855-6dac-45ed-8597-0541bddd3bce)
- [GlaxoSmithKline Biologicals](https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808)
- [Dr. Reddy’s Laboratories Limited](https://www.keypedia.com/companies/dr-reddys-laboratories-limited/19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6)

## Related Officers

- [Microbiologist ](https://www.keypedia.com/people/doan-t-nguyen/2b1112b4-01b8-4581-82f2-86cbe29c8857)
- [Compliance Officer](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)